Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
2023 Czech Republic Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... other published source , including 2022 supplier strategies and shares, and 2022-2027 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and ... Read More
-
2023 Haiti Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... published source , including 2022 supplier strategies and shares, and 2022-2027 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and products ... Read More
-
2023 Qatar Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... published source , including 2022 supplier strategies and shares, and 2022-2027 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and products ... Read More
-
2023 Uruguay Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... published source , including 2022 supplier strategies and shares, and 2022-2027 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and products ... Read More
-
Bladder Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... be more than 460,000 diagnosed incident cases of bladder cancer across 16 pharmaceutical markets. There are a good number of marketed innovator drugs for the treatment of bladder cancer, mostly checkpoint inhibitors. The bladder cancer ... Read More
-
Global Cancer Minimal Residual Disease Testing Market Growth 2023-2029
... result means that disease was still detected after treatment. An MRD negative result means that no disease was detected after treatment. LPI (LP Information)' newest research report, the “Cancer Minimal Residual Disease Testing Industry Forecast” ... Read More
-
Global Checkpoint Inhibitor Refractory Cancer Market Growth (Status and Outlook) 2023-2029
... Cancer sales in 2022, providing a comprehensive analysis by region and market sector of projected Checkpoint Inhibitor Refractory Cancer sales for 2023 through 2029. With Checkpoint Inhibitor Refractory Cancer sales broken down by region, market ... Read More
-
Ovarian Cancer - Drug Pipeline Landscape, 2023
... on the origination in cell types which are epithelial ovarian cancer, stromal tumor and germ cell tumor. The exact cause of Ovarian cancer is still unclear but the risk factors include family history of ovarian/breast ... Read More
-
Europe Prostate Cancer Diagnosis and Therapy Market Research Report Forecast to 2027
... a CAGR of 5.05% during the assessment period. Prostate cancer is a type of cancer that affects only males in the prostate gland cells and is highly treatable in the early stages. There are various ... Read More
-
Global Pancreatic Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Stage II, Stage III and Stage IV), Tumor Type(Exocrine Tumors and Neuroendocrine Tumors), Product (Instrument-Based Products, Platform-Based Products, Kits and Reagents, and Other Consumables), Technology (Fluorescent In Situ Hybridization, Next Generation Sequencing, Fluorimmunoassay, Comparative Genomic ... Read More
-
Global Breast Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Carcinoma, Inflammatory Breast Cancer, and Metastatic Breast Cancer), End User (Hospitals, Clinics, Research and Academic Institutes, Diagnostic Centres, and Others) Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, and Mexico, Germany, France, ... Read More
-
Global Thyroid Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Carcinoma, Follicular Carcinoma, Others), Stages (Stage I, Stage II, Stage III, Stage IV), Age Group ( 30-65, 65 and above, 21-29, Below 21), End User (Hospitals, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer ... Read More
-
Global Brain Cancer Diagnostic Market - Industry Trends and Forecast to 2030
... Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others), Age Group (Below 21,21-34, 35-65 and 65, and Above), End User (Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others), Region (North America, Europe, ... Read More
-
Minimal Residual Disease Market Share, Size, Trends, Industry Analysis Report, By Detection Target (Lymphoma, Leukemia, Solid Tumors, Others); By Test Technique; By End-User; By Region; Segment Forecast, 2023-2032
... is expected to reach USD 7,131.61 million by 2032, according to a new study by Polaris Market Research. The report “Minimal Residual Disease Market Share, Size, Trends, Industry Analysis Report, By Detection Target (Lymphoma, Leukemia, ... Read More
-
Europe Thyroid Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Carcinoma, Follicular Carcinoma, Others), Stages (Stage I, Stage II, Stage III, Stage IV), Age Group (30-65, 65 and Above, 21-29, Below 21), End Users (Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research ... Read More
-
MEA Brain Cancer Diagnostic Market - Industry Trends and Forecast to 2030
... Type (Acoustic Neuroma, Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others), Age Group (Below 21,21-34, 35-65, and 65 and Above), End User (Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others), Country ... Read More
-
NA Throat Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Cancer Type (Pharyngeal Cancer and Laryngeal Cancer), Stages (Stage 0, Stage I, Stage II, Stage III and Stage IV), Age Group (30-65, 65 and above, 21-29 and Below 21), End User (Hospitals, Associated Labs, Independent ... Read More
-
APAC Pancreatic Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Stage II, Stage III and Stage IV), Tumor Type(Exocrine Tumors and Neuroendocrine Tumors), Product (Instrument-Based Products, Platform-Based Products, Kits and Reagents, and Other Consumables), Technology (Fluorescent In Situ Hybridization, Next Generation Sequencing, Fluorimmunoassay, Comparative Genomic ... Read More
-
MEA Pancreatic Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... 0, Stage I, Stage II, Stage III and Stage IV), Tumor Type(Exocrine Tumors and Neuroendocrine Tumors), Product (Instrument-Based Products, Platform-Based Products, Kits and Reagents, and Other Consumables), Technology (Fluorescent In Situ Hybridization, Next Generation Sequencing, ... Read More
-
NA Brain Cancer Diagnostic Market - Industry Trends and Forecast to 2030
... Neuroma, Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others), Age Group (Below 21,21-34, 35-65, and 65 and Above), End User (Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others), Country (U.S., Canada, ... Read More
-
Europe Breast Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Carcinoma, Inflammatory Breast Cancer, and Metastatic Breast Cancer), End User (Hospitals, Clinics, Research and Academic Institutes, Diagnostic Centers, and Others) Distribution Channel (Direct Tender, Retail Sales, and Others), Country (Germany, France, U.K., Italy, Russia, Spain, ... Read More
-
APAC Brain Cancer Diagnostic Market - Industry Trends and Forecast to 2030
... Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others), Age Group (Below 21,21-34, 35-65, and 65 and Above), End User (Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others, Country (China, Japan, South ... Read More
-
Europe Brain Cancer Diagnostic Market - Industry Trends and Forecast to 2030
... Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others), Age Group (Below 21,21-34, 35-65, and 65 and Above), End User (Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others), Country (Russia, Spain, Turkey, ... Read More
-
Europe Pancreatic Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Stage II, Stage III and Stage IV), Tumor Type(Exocrine Tumors and Neuroendocrine Tumors), Product (Instrument-Based Products, Platform-Based Products, Kits and Reagents, and Other Consumables), Technology (Fluorescent In Situ Hybridization, Next Generation Sequencing, Fluorimmunoassay, Comparative Genomic ... Read More
-
NA Breast Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Ductal Carcinoma, Inflammatory Breast Cancer, and Metastatic Breast Cancer), End User (Hospitals, Clinics, Research and Academic Institutes, Diagnostic Centres, and Others) Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, and Mexico) Industry ... Read More
Research Assistance
